Is CBD legal in Uruguay?

Legal status

Not placed, and the finding now rests on the current list rather than a superseded one. Cannabidiol is not named in the national list enacted by Decreto 198/025 of 25 September 2025: anchored searches on cannabidiol and on cbd across all 526 entries returned no entry; the cannabis entries that exist are cannabis and resina de cannabis y extractos y tinturas de cannabis at Lista Amarilla in Anexo I, and the six THC isomers, dronabinol and hexahidrocannabinol in Anexo II. The weakness the earlier cell disclosed is now closed and the closure is stated plainly. Article 6 of Decreto 198/025 does not add to the 2020 annex, it replaces the whole consolidated list, and article 8 creates a control with no counterpart anywhere in Decreto 265/020: "Quedan sujetas a control todas aquellas sustancias que se encuadren dentro de los grupos genericos incluidos en el ANEXO II", all substances falling within the generic groups of its Anexo II. Those annexes are published only as Diario Oficial page images, and they have now been read: the edition of 3 October 2025, number 31.766, carillas 7 to 24, fetched one page image at a time from the Diario Oficial image service, read by eye off the page and checked against a Spanish optical character recognition pass, with the eye preferred wherever the two disagreed. Anexo I, Estupefacientes, carries 173 entries at carillas 7 to 12. Anexo II, Sicotropicos, carries 278 entries at carillas 12 to 21 and ends with three generic groups, Feniletilaminas and Catinonas sinteticas, each classed Sicotropicos Lista I, and Derivados de Fentanilo, classed Estupefacientes Lista I. Anexo III carries 75 entries in Tablas I and II at carillas 22 to 24. 526 entries in all. The name column was transcribed by eye and every search below was run against that transcription, not against the optical character recognition text, because the recognition text is not a sound basis for an absence: measured against the transcription, it carries only 396 of the 526 names, 9 of the 29 on carilla 22 and none of the 14 on carilla 24, where it captured the CAS and control columns and dropped the substance column altogether. A search run against it alone would return a false zero for about a quarter of the list [Certain, re-derived here; an independent count by the coordinator using a different normaliser returned 400 rather than 396, and both figures are floors because a misspelling counts as a miss]. This row was tested against each of the three generic groups in turn and is caught by none of them, being a non-intoxicating cannabinoid, and no cannabinoid group exists in Anexo II. [Certain as to what the annexes print.] This is a bounded, dated finding of absence and not an epistemic failure, which is why it opens positively. The b176 cell reached the same outcome but rested it on the Anexo I of Decreto 265/020, a list the same decreto has since replaced, and disclosed that the generic groups had never been read. That disclosure is discharged here. One question is not closed by it: article 6 of Decreto 198/025 extends control to the listed substances' derivatives "segun las definiciones de estos", and no such definitions are printed in any of the three annexes, whose own notes reach only isomers, salts and the products containing them [Certain as to both wordings]. Nothing listed stands close enough to this substance for that limb to bite [Likely]. The version horizon, stated outright because an absence without one expires silently and says nothing about having expired: the list read is the one enacted by Decreto 198/025 of 25 September 2025, published in the Diario Oficial of 3 October 2025, which is the current consolidated national list and replaces the Anexo I of Decreto 265/020 that the earlier cell searched. The power that moves it is article 15 of Decreto-Ley 14.294 in the wording given to it by article 2 of Ley 17.016, and article 8 of Decreto 198/025 subjects substances to control by generic group rather than by name. The annexes were read as at 25 September 2025, the date of the decreto that enacts them and the last amendment the text in hand incorporates. This does not rule out a later individual entry, a later replacement of the annexes, or a later generic group.

Consequences if caught

Capital exposure: none. Article 26 of the Constitution provides that "A nadie se le aplicará la pena de muerte", no one shall have the death penalty applied to them, and no limb of Decreto-Ley 14.294 provides a capital sentence [Certain]. Cannabidiol carries no entry in the national list, so no offence article of Decreto-Ley 14.294 attaches to it by name. The line that does matter is the tetrahydrocannabinol content: a preparation at or above one per cent is cannabis psicoactivo under article 3 and falls inside the cannabis regime and its offences, while one below one per cent is hemp. A cannabidiol product that is over the line, or one that is an extract or tincture of cannabis rather than a registered hemp medicine, is reached by the entry "resina de cannabis y extractos y tinturas de cannabis" at Lista Amarilla, Lista I, and then by article 31, which punishes unauthorised import, transport, possession not for one’s own consumption and offering for sale with two to twelve years of penitenciaría [Likely]. Uruguay’s published penalties are set out at the cannabis row. They are the country’s penalties for psychoactive cannabis and they are not this row’s exposure where the product is a registered hemp medicine below the threshold. Article 36 follows the same split: its numerals 1 and 6 are limited in terms to "las sustancias a que se refiere el artículo 1° de la presente ley", so they reach an over threshold preparation through the cannabis entry and do not reach a compliant hemp medicine, while numerals 4 and 5 speak of "el delito" generically [Certain as to the wording]. The b176 cell recorded that this substance could not be placed in any list, and disclosed that the generic groups of Anexo II had never been read. Both annexes have now been read: Cannabidiol is absent from the 526 entry name column of the list in force and is caught by none of the three generic groups, being a non-intoxicating cannabinoid, and no cannabinoid group exists in Anexo II. So the ranges above remain the country's published penalties and are still not this row's exposure, and that conclusion now rests on the list in force rather than on the one it replaced.

If prescribed or medical

This is the one row in this set with a positive prescription answer in the primary text. Decreto 298/017 article 1 puts registered cannabidiol specialties made from hemp below one per cent tetrahydrocannabinol on sale under professional prescription, and article 2 confines dispensing to first and second category pharmacies under Decreto-Ley 15.703 against that prescription [Certain]. The product must be registered and authorised by the medicines department of the health ministry, so a foreign cannabidiol product is not automatically within the authorisation. Article 111 of Decreto 454/976 prohibits outright the circulation in transit through national territory of narcotic or psychopharmacological substances coming from and destined for abroad. No traveller allowance for carrying a personal supply was found in the reachable official text, so that question is deferred.

Documentation

Carry the product in its original packaging with the professional prescription and declare it. The tetrahydrocannabinol content is the fact that decides this row, so documentation showing the product is a hemp derived preparation below one per cent is the material thing to hold. Legal psychoactive cannabis access in Uruguay is a separate regime restricted to registered citizens and accredited permanent residents, see the cannabis row.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Uruguay’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.